<?xml version="1.0" encoding="ISO-8859-1"?>
<LTDLWOCR>
<!-- forcebtag -->
<tid>aad00d00</tid>
<bt>50313870/3870</bt>
<dd>19870520</dd>
<dt>LETTER</dt>
<au>LIMBIRD LE, VANDERBILT UNIV SCHOOL MEDICINE</au>
<rc>LANIER S, HARVARD MEDICAL SCHOOL; LANIER S, MA GENERAL HOSPITAL</rc>
<!-- Note:d:PROVISION OF AFFINITY-PURIFIED RECEPTOR FOR STUDY OF STRUCTURAL FEATURES OF THE PORCINE BRAIN CORTEX ALPHA2-ADREERGIC RECEPTOR-->
<!-- Note:dl:20010130-->
<pg>1</pg>
<dl>20021115</dl>
<ot>VANDERBILT UNIVERSITY
NASHI'1LLF., TF.NNLSSE:F. 37232
Tri F rno.e 1615I 322-5000
DeparU~tcu! n/ Phdrm,~i~~ingt • Srhool of ,S1nlt2'ine • Dird&lt;1 pharn 322220i
May 20, 1987
Dr. Steve Lanier
Cardiac Unit
Massachusetts General Hospital
Harvard Medical School
Jackson-13
Boston, MA 02114
Dear Steve:
I am delighted to confirm in writing our on-going collaboration to study certain
structural features of the porcine brain cortex alpha2-adrenergic receptor. We are
pleased to continue providing affinity-purified receptor for your analyses of the possible
structural heterogeneity among alpha2-adrenergic receptors from brain, kidney, spleen
and platelet. As you are well aware, recent reports suggesting the possible existence of
alpha2-receptor subtypes (based on radioligand binding and functional criteria) make these
studies all the more interesting and important.
Best of luck in obtaining adequate funding to pursue these studies.
Sincerely,
YU.
Lee E. Limbird, Ph.D.
Professor
Department of Pharmacology
LEL/mc
•
Au Equnl Oppmhurih/AJ/trmnlti~r Adron Enplq~rr

pgNbr=1
</ot>
</LTDLWOCR>
